Immo Serbian
Impact in
- Toxicology top 10%
-
- Cholinesterase and Neurodegenerative Diseases
- Pharmacological Effects of Natural Compounds
Papers in
-
- Natural product bioactivities and synthesis 19
- Plant biochemistry and biosynthesis 8
- Phytochemical compounds biological activities 3
- Chemical Synthesis and Analysis 3
- Enzyme function and inhibition 3
- Pharmacology 14
- Cholinesterase and Neurodegenerative Diseases 10
- Co-authors
- René Csük (33 shared papers)Sophie Hoenke (16 shared papers)Anne Loesche (8 shared papers)Hans‐Peter Deigner (3 shared papers)Ahmed Al‐Harrasi (8 shared papers)Sven Sommerwerk (2 shared papers)Lucie Heller (1 shared paper)Bianka Siewert (2 shared papers)
In The Last Decade
Immo Serbian
33 papers receiving 392 citations
Peers
Comparison fields: 5 of 69
- Toxicology 23
- Pharmacology 77
- Pharmacology 38
- Molecular Biology 287
- Complementary and alternative medicine 27
Countries citing papers authored by Immo Serbian
This map shows the geographic impact of Immo Serbian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Immo Serbian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Immo Serbian more than expected).
Fields of papers citing papers by Immo Serbian
This network shows the impact of papers produced by Immo Serbian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Immo Serbian. The network helps show where Immo Serbian may publish in the future.
Co-authors
The 25 scholars most cited alongside Immo Serbian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 42 | |
| 2 | 2015 | 31 | |
| 3 | 2019 | 21 | |
| 4 | 2020 | 21 | |
| 5 | 2015 | 21 | |
| 6 | 2019 | 20 | |
| 7 | 2020 | 20 | |
| 8 | 2020 | 18 | |
| 9 | 2020 | 17 | |
| 10 | 2021 | 16 | |
| 11 | 2019 | 15 | |
| 12 | 2022 | 15 | |
| 13 | 2022 | 14 | |
| 14 | 2019 | 13 | |
| 15 | 2020 | 13 | |
| 16 | 2018 | 12 | |
| 17 | 2021 | 11 | |
| 18 | 2019 | 10 | |
| 19 | 2022 | 9 | |
| 20 | 2019 | 9 |
About Immo Serbian
Immo Serbian is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Plant Science and Complementary and alternative medicine, having authored 33 papers that have together received 394 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (19 papers), Cholinesterase and Neurodegenerative Diseases (10 papers), Plant biochemistry and biosynthesis (8 papers), Carbohydrate Chemistry and Synthesis (5 papers), Phytochemical compounds biological activities (3 papers), Synthesis and biological activity (3 papers), Chemical Synthesis and Analysis (3 papers) and Enzyme function and inhibition (3 papers). The work is most often cited by research in Toxicology (23 citations), Pharmacology (77 citations), Pharmacology (38 citations), Molecular Biology (287 citations) and Complementary and alternative medicine (27 citations). Immo Serbian has collaborated with scholars based in Germany, Oman and Russia. Frequent co-authors include René Csük, Sophie Hoenke, Anne Loesche, Hans‐Peter Deigner, Ahmed Al‐Harrasi, Sven Sommerwerk, Lucie Heller, Bianka Siewert, О. Б. Казакова and Wolfgang Brandt. Their work appears in journals such as European Journal of Medicinal Chemistry, Molecules, Medicinal Chemistry Research, Phytochemistry Letters and Bioorganic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.